DIA Biosimilars 2013

PPD

PPD to Cut 270 Employees in North America

Tuesday, July 14, 2009 07:00 AM

Wilmington, N.C.-based contract research organization (CRO) PPD is laying off a total of 270 employees in North America, including 80 employees from its North Carolina headquarters.

More... »

Cenduit: Now with Patient Reminders

PPD Appoints New CEO, Eshelman to Serve as Executive Director of Board

Wednesday, May 20, 2009 07:00 AM

Wilmington, N.C.-based PPD is promoting current CEO Fred Eshelman to the newly created position of executive chairman of the board of directors, effective July 1.

More... »

CRF Health – eCOA Forum

PPD Earnings Down in Q1, Opens Office in Japan

Wednesday, April 22, 2009 08:00 AM

Wilmington, N.C-based contract research organization (CRO) PPD reported first quarter 2009 earnings late yesterday along with the opening of its first office in Japan and the completion of the acquisition of AbCRO, a Bulgarian CRO.

More... »

PPD Acquires Magen BioSciences, Plans to Sell Piedmont Research

Friday, April 3, 2009 02:00 PM

PPD acquired Magen BioSciences, a dermatology-focused biotechnology company—just as the contract research organization (CRO) announced plans to divest its preclinical research subsidiary Piedmont Research Center.

More... »

PPD Earnings up 18% in Q4, Plans to Acquire AbCRO

Tuesday, February 10, 2009 07:00 AM

Wilmington, N.C.-based CRO PPD reported full-year and fourth quarter 2008 earnings late yesterday, reflecting an 11% increase in its full year revenues despite a slight decrease in fourth quarter revenues.

More... »

Parexel Names New CIO

Friday, January 16, 2009 09:04 AM

Josephine Hoppe has joined contract research organization (CRO) Parexel as corporate vice president and chief information officer (CIO). Hoppe will handle Parexel’s IT initiatives and manage the integration of technology solutions with global business processes. Prior to joining Parexel, Hoppe was the CIO of Pegasystems, a business process management company.

More... »

PPD Projects 12% Growth in 2009

Thursday, January 15, 2009 10:48 AM

Wilmington, N.C.-based PPD expects net revenue for 2009 to be in the range of $1.595 to $1.670 billion, a 12% increase over the CRO’s 2008 net revenue forecast. The company projects diluted earnings per share (EPS) for the full year 2009 will be in the range of $1.97 to $2.05, an 18% increase over its full year 2008 EPS forecast.

More... »

PPD and Merck in Strategic Outsourcing Deal

Tuesday, January 6, 2009 11:25 AM

Contract research organization (CRO) PPD has entered into a strategic collaboration with Merck that will significantly expand PPD’s global central laboratory business.

More... »

PPD 3Q Earnings Up, Cuts 2008 Guidance

Wednesday, October 22, 2008 09:04 AM

PPD, a contract research organization (CRO), reported third quarter revenue increased 11.6% to $398.5 compared with $357.2 million for the third quarter of 2007. Diluted earnings per share jumped 34% to $0.43 per share.

More... »

JDRF Names PPD Preferred Provider

Monday, October 20, 2008 09:00 AM

The Juvenile Diabetes Research Foundation (JDRF), the world’s largest charitable funder of type 1 diabetes research, has teamed up with global contract research organization (CRO) PPD in a unique partnership designed to improve clinical research for type 1 diabetes.

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs